Metabolic Health & Biomarkers

Original derivation of the HOMA-IR formula from fasting glucose and insulin. Matthews 1985 published the SI form: HOMA-IR = [fasting insulin (μU/mL) × fasting glucose (mmol/L)] / 22.5. The app uses the mathematically equivalent mg/dL form: (glucose mg/dL × insulin μU/mL) / 405. The app reports your raw HOMA-IR value rather than classifying it into a category, because population thresholds for insulin resistance vary substantially across ethnic and national groups (see Esteghamati 2010 and Geloneze 2009 below for population-specific examples). The original Matthews paper derived the formula from a 36-subject methodological cohort and did not itself define population cutoffs. Discuss your value with your healthcare provider for interpretation in the context of your specific population, BMI, fasting state, and other lab markers.

National-level Iranian study of 3,071 adults aged 25–64. Optimal HOMA-IR cutoff for diagnosing metabolic syndrome was approximately 1.95 (ATP-III criteria) — substantially lower than cutoffs reported in European or Latin American populations, illustrating that interpretation of HOMA-IR depends on population characteristics including ethnic background, BMI distribution, and dietary patterns.

Brazilian Metabolic Syndrome Study (n=1,203 nondiabetic adults aged 18–78). Optimal HOMA1-IR cutoff for insulin resistance was 2.7, derived from the 90th percentile of a healthy reference subgroup. The cutoff is meaningfully higher than values reported in Iranian or East Asian populations, again illustrating that thresholds applied to HOMA-IR are population-dependent.

Consensus statement by 26 researchers reviewing the evidence for dietary carbohydrate restriction in insulin resistance and type 2 diabetes. Demonstrated that reducing dietary carbohydrate lowers postprandial glucose and insulin, reduces HOMA-IR, and decreases HbA1c more reliably than any other dietary intervention. High-protein, lower-carbohydrate diets improve insulin sensitivity independent of weight loss — directly informing carb-periodisation strategies for metabolically compromised trainees.

Comprehensive review of exercise-induced improvements in insulin sensitivity. A single bout of moderate-intensity exercise improves insulin sensitivity for 24–72 hours via GLUT4 translocation independent of insulin. Resistance training additionally increases GLUT4 expression chronically. Combined aerobic + resistance training reduces HOMA-IR by 20–30% over 12 weeks — demonstrating why logging both cardio and weightlifting sessions is metabolically meaningful beyond calorie burn.

Meta-analysis of 54 RCTs (n=1,900) examining dietary glycaemic index (GI) and load effects on HbA1c. Lower-GI diets reduced HbA1c by 0.5–0.6% in people with type 2 diabetes and by ~0.1% in non-diabetic individuals. HbA1c reflects mean blood glucose over 8–12 weeks, making it a sensitive long-term biomarker of habitual diet quality. Foods that minimise postprandial glucose spikes (high-fibre, minimally processed) are most protective.

Meta-analysis of 9 prospective cohorts (n>500,000) showing each 10% increment in ultra-processed food proportion of diet was associated with a 15% higher risk of type 2 diabetes. The association persisted after adjusting for BMI, suggesting direct metabolic toxicity beyond adiposity — via additives, advanced glycation end-products, and disrupted gut microbiota — providing mechanistic support for the food quality scoring algorithm used in this platform.

Landmark analysis of the AMORIS cohort (n=175,553) demonstrating ApoB predicts cardiovascular events more accurately than LDL-C, especially in individuals with metabolic syndrome or high triglycerides. ApoB counts every atherogenic lipoprotein particle (LDL, VLDL, IDL), whereas LDL-C can be normal in people with high particle number (the "LDL paradox"). Dietary advice that reduces LDL-C without reducing ApoB may underestimate residual CVD risk.

Recovery and analysis of the Minnesota Coronary Experiment, an RCT (n=9,423) showing replacing saturated fat with vegetable oils (high omega-6 linoleic acid) lowered total cholesterol but increased CVD mortality. Omega-6-driven LDL reduction without parallel ApoB reduction does not equate to reduced CVD risk. This challenges simplistic "lower cholesterol = better" dietary messaging and highlights why ApoB, LDL particle size, and inflammatory markers provide more clinically actionable lipid data.

AHA science advisory concluding that dietary cholesterol has minimal direct effect on plasma LDL-C for most people (cholesterol is tightly regulated via hepatic feedback). Eggs, previously demonised, raise large buoyant LDL (minimally atherogenic) rather than small dense LDL. The harmful dietary pattern driving ApoB elevation is high-refined-carbohydrate + high-saturated-fat combined with low fibre — not dietary cholesterol in isolation.

Harmonised international criteria for metabolic syndrome: any 3 of — elevated waist circumference (≥94 cm men, ≥80 cm women); triglycerides ≥1.7 mmol/L; HDL <1.0/1.3 mmol/L (M/F); BP ≥130/85 mmHg; fasting glucose ≥5.6 mmol/L. MetSyn increases CVD risk 2× and T2DM risk 5×. The waist circumference criterion is key: visceral fat (not subcutaneous) drives cytokine-mediated inflammation and hepatic insulin resistance, explaining why body fat distribution matters beyond total BMI.

Comprehensive review of energy balance components relevant to visceral fat accumulation. Excess refined carbohydrates and fructose preferentially drive hepatic de novo lipogenesis (DNL), depositing visceral and ectopic fat disproportionately versus dietary fat of equal calories. Resistance training uniquely targets visceral fat via AMPK activation and improved hepatic insulin sensitivity, producing greater visceral fat loss than aerobic exercise of equivalent caloric expenditure in several RCTs.